Financial Snapshot

Revenue
$8.969M
TTM
Gross Margin
63.92%
TTM
Net Earnings
-$17.62M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
203.41%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$3.179M
Q3 2024
Cash
Q3 2024
P/E
-0.4840
Nov 13, 2024 EST
Free Cash Flow
-$8.387M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Revenue $8.864M $8.543M $7.921M $7.441M $5.511M $4.998M $3.550M $1.290M $60.00K $300.0K $59.00K $0.00 $0.00 $410.0K $310.0K $390.0K $2.530M $1.260M $380.0K $20.00K $330.0K $330.0K
YoY Change 3.76% 7.85% 6.45% 35.02% 10.26% 40.79% 175.19% 2050.0% -80.0% 408.47% -100.0% 32.26% -20.51% -84.58% 100.79% 231.58% 1800.0% -93.94% 0.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Revenue $8.864M $8.543M $7.921M $7.441M $5.511M $4.998M $3.550M $1.290M $60.00K $300.0K $59.00K $0.00 $0.00 $410.0K $310.0K $390.0K $2.530M $1.260M $380.0K $20.00K $330.0K $330.0K
Cost Of Revenue $3.881M $3.788M $3.430M $3.384M $2.660M $3.670M $2.760M $710.0K
Gross Profit $4.983M $4.755M $4.491M $4.057M $2.851M $1.328M $790.0K $580.0K
Gross Profit Margin 56.22% 55.66% 56.7% 54.52% 51.73% 26.57% 22.25% 44.96%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Selling, General & Admin $17.19M $17.58M $19.04M $17.42M $16.29M $15.31M $10.17M $8.130M $8.350M $9.210M $9.426M $6.866M $5.363M $3.330M $3.310M $3.630M $2.900M $1.950M $1.750M $750.0K $420.0K $420.0K
YoY Change -2.23% -7.64% 9.31% 6.95% 6.36% 50.55% 25.09% -2.63% -9.34% -2.29% 37.29% 28.03% 61.05% 0.6% -8.82% 25.17% 48.72% 11.43% 133.33% 78.57% 0.0%
% of Gross Profit 344.99% 369.8% 423.94% 429.31% 571.2% 1152.94% 1287.34% 1401.72%
Research & Development $5.422M $4.342M $4.978M $3.668M $4.672M $3.053M $1.480M $8.110M $17.67M $16.87M $13.50M $8.003M $11.20M $3.050M $2.290M $4.790M $8.080M $4.430M $2.410M $470.0K $320.0K $320.0K
YoY Change 24.87% -12.78% 35.71% -21.49% 53.03% 106.28% -81.75% -54.1% 4.74% 24.93% 68.74% -28.54% 267.18% 33.19% -52.19% -40.72% 82.39% 83.82% 412.77% 46.88% 0.0%
% of Gross Profit 108.81% 91.31% 110.84% 90.41% 163.87% 229.89% 187.34% 1398.28%
Depreciation & Amortization $362.0K $372.0K $488.0K $376.0K $239.0K $232.0K $770.0K $700.0K $330.0K $280.0K $185.0K $138.0K $50.00K $50.00K $50.00K $70.00K $50.00K $30.00K $30.00K $20.00K $10.00K $10.00K
YoY Change -2.69% -23.77% 29.79% 57.32% 3.02% -69.87% 10.0% 112.12% 17.86% 51.35% 34.06% 176.0% 0.0% 0.0% -28.57% 40.0% 66.67% 0.0% 50.0% 100.0% 0.0%
% of Gross Profit 7.26% 7.82% 10.87% 9.27% 8.38% 17.47% 97.47% 120.69%
Operating Expenses $22.61M $21.93M $24.02M $21.09M $20.96M $18.36M $11.66M $16.24M $26.02M $26.08M $22.93M $14.87M $16.56M $6.770M $5.960M $9.110M $11.58M $6.730M $4.530M $1.250M $750.0K $750.0K
YoY Change 3.13% -8.71% 13.91% 0.61% 14.12% 57.5% -28.2% -37.59% -0.23% 13.74% 54.21% -10.22% 144.64% 13.59% -34.58% -21.33% 72.07% 48.57% 262.4% 66.67% 0.0%
Operating Profit -$17.63M -$17.17M -$19.53M -$17.03M -$18.11M -$17.04M -$10.87M -$15.66M -$22.87M -$14.87M -$16.56M
YoY Change 2.67% -12.06% 14.67% -5.95% 6.28% 56.72% -30.59% 53.82% -10.22%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Interest Expense -$3.483M $2.580M $0.00 $1.200M $0.00 $1.480M $310.0K -$740.0K $30.00K $250.0K -$90.00K -$290.0K $0.00 $0.00 $0.00 -$20.00K $0.00 $0.00 $0.00
YoY Change -235.0% -100.0% -100.0% 377.42% -141.89% -88.0% -377.78% -68.97% -100.0%
% of Operating Profit
Other Income/Expense, Net $912.0K $75.00K -$43.00K -$1.000K $0.00 $10.00K -$40.00K $0.00 -$10.00K -$50.00K -$100.0K $33.00K
YoY Change 1116.0% -274.42% 4200.0% -100.0% -125.0% -100.0% -80.0% -50.0% -403.03%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Pretax Income -$20.20M -$14.52M -$19.57M -$15.83M -$18.11M -$17.03M -$13.38M -$15.85M -$26.71M -$25.84M -$22.01M -$13.37M -$11.25M -$6.440M -$5.940M -$8.710M -$9.060M -$5.470M -$4.180M -$1.220M -$1.730M -$1.730M
YoY Change 39.16% -25.82% 23.64% -12.59% 6.34% 27.25% -15.58% -40.66% 3.37% 17.39% 64.61% 18.85% 74.72% 8.42% -31.8% -3.86% 65.63% 30.86% 242.62% -29.48% 0.0%
Income Tax $8.000K $9.000K $9.000K $9.000K $8.000K $6.000K $10.00K -$50.00K -$120.0K -$250.0K -$1.213M -$771.0K -$115.0K -$690.0K $0.00 $0.00 $0.00 -$220.0K $0.00 -$190.0K $0.00 $0.00
% Of Pretax Income
Net Earnings -$22.63M -$14.53M -$19.58M -$15.84M -$18.11M -$17.03M -$13.38M -$15.79M -$26.58M -$25.59M -$21.76M -$14.07M -$16.20M -$5.750M -$5.940M -$8.710M -$9.060M -$5.260M -$4.180M -$1.030M -$1.730M -$1.730M
YoY Change 55.78% -25.81% 23.63% -12.58% 6.35% 27.29% -15.26% -40.59% 3.87% 17.6% 54.66% -13.15% 181.74% -3.2% -31.8% -3.86% 72.24% 25.84% 305.83% -40.46% 0.0%
Net Earnings / Revenue -255.27% -170.02% -247.17% -212.82% -328.69% -340.78% -376.9% -1224.03% -44300.0% -8530.0% -36881.36% -1402.44% -1916.13% -2233.33% -358.1% -417.46% -1100.0% -5150.0% -524.24% -524.24%
Basic Earnings Per Share -$11.52 -$83.55 -$2.87 -$10.67
Diluted Earnings Per Share -$11.52 -$83.55 -$2.87 -$10.67 -$226.4M -$1.703B -$15.77B -$225.2B -$369.7B -$381.6B -$431.0B -$499.4B -$750.1B -$2.922B -$4.988B -$10.45B -$13.89B -$14.59B -$16.71B -$14.34B -$46.78B -$46.78B

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Cash & Short-Term Investments $3.800M $18.31M $24.21M $14.44M $1.280M $5.480M $15.60M $1.320M $23.11M $31.29M $54.14M $14.22M $6.560M $3.310M $1.620M $9.360M $6.550M $3.360M $6.010M $930.0K $1.170M $1.170M
YoY Change -79.24% -24.37% 67.62% 1028.13% -76.64% -64.87% 1081.82% -94.29% -26.14% -42.21% 280.73% 116.77% 98.19% 104.32% -82.69% 42.9% 94.94% -44.09% 546.24% -20.51% 0.0%
Cash & Equivalents $3.800M $17.74M $24.21M $14.44M $1.280M $5.480M $15.60M $1.320M $23.11M $31.29M $54.14M $14.22M $6.560M $6.550M $3.360M $6.010M $930.0K $1.170M $1.170M
Short-Term Investments $0.00 $569.0K $2.430M $0.00 $7.140M $7.140M
Other Short-Term Assets $461.0K $396.0K $328.0K $240.0K $160.0K $200.0K $140.0K $140.0K $480.0K $360.0K $450.0K $330.0K $350.0K $130.0K $80.00K $90.00K $100.0K $960.0K $910.0K $390.0K $20.00K $20.00K
YoY Change 16.41% 20.73% 36.67% 50.0% -20.0% 42.86% 0.0% -70.83% 33.33% -20.0% 36.36% -5.71% 169.23% 62.5% -11.11% -10.0% -89.58% 5.49% 133.33% 1850.0% 0.0%
Inventory $1.997M $2.661M $2.843M $2.960M $1.800M $1.660M $1.590M $680.0K $0.00
Prepaid Expenses
Receivables $1.951M $1.406M $750.0K $910.0K $800.0K $790.0K $550.0K $280.0K $0.00 $60.00K $60.00K $150.0K $110.0K $0.00 $0.00 $10.00K $30.00K $30.00K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $720.0K $20.00K $60.00K $60.00K $10.00K $50.00K $50.00K
Total Short-Term Assets $8.209M $22.77M $28.13M $18.54M $4.040M $8.130M $17.86M $2.420M $23.59M $31.71M $54.64M $14.56M $6.910M $4.310M $1.830M $9.510M $6.810M $4.340M $7.000M $1.330M $1.190M $1.190M
YoY Change -63.95% -19.05% 51.7% 358.91% -50.31% -54.48% 638.02% -89.74% -25.61% -41.97% 275.27% 110.71% 60.32% 135.52% -80.76% 39.65% 56.91% -38.0% 426.32% 11.76% 0.0%
Property, Plant & Equipment $1.441M $1.883M $2.270M $1.460M $1.430M $540.0K $570.0K $540.0K $540.0K $660.0K $590.0K $480.0K $520.0K $110.0K $150.0K $240.0K $300.0K $190.0K $130.0K $70.00K $90.00K $90.00K
YoY Change -23.47% -17.05% 55.48% 2.1% 164.81% -5.26% 5.56% 0.0% -18.18% 11.86% 22.92% -7.69% 372.73% -26.67% -37.5% -20.0% 57.89% 46.15% 85.71% -22.22% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $120.0K $21.00K $21.00K $20.00K $130.0K $110.0K $20.00K $20.00K $320.0K $0.00 $0.00 $0.00 $220.0K $510.0K $0.00 $0.00
YoY Change 471.43% 0.0% 5.0% -84.62% 18.18% 450.0% 0.0% -93.75% -100.0% -56.86%
Total Long-Term Assets $1.561M $1.904M $2.291M $1.470M $1.560M $650.0K $600.0K $5.050M $860.0K $660.0K $590.0K $480.0K $520.0K $110.0K $150.0K $240.0K $300.0K $410.0K $640.0K $80.00K $90.00K $90.00K
YoY Change -18.01% -16.89% 55.85% -5.77% 140.0% 8.33% -88.12% 487.21% 30.3% 11.86% 22.92% -7.69% 372.73% -26.67% -37.5% -20.0% -26.83% -35.94% 700.0% -11.11% 0.0%
Total Assets $9.770M $24.67M $30.42M $20.01M $5.600M $8.780M $18.46M $7.470M $24.45M $32.37M $55.23M $15.04M $7.430M $4.420M $1.980M $9.750M $7.110M $4.750M $7.640M $1.410M $1.280M $1.280M
YoY Change
Accounts Payable $2.380M $2.245M $1.414M $1.100M $1.490M $1.130M $860.0K $2.350M $2.830M $2.080M $2.190M $1.160M $1.860M $380.0K $280.0K $150.0K $160.0K $20.00K $180.0K $190.0K $60.00K $60.00K
YoY Change 6.01% 58.77% 28.55% -26.17% 31.86% 31.4% -63.4% -16.96% 36.06% -5.02% 88.79% -37.63% 389.47% 35.71% 86.67% -6.25% 700.0% -88.89% -5.26% 216.67% 0.0%
Accrued Expenses $741.0K $2.357M $1.831M $2.400M $1.780M $1.500M $1.020M $910.0K $1.370M $1.080M $1.320M $930.0K $980.0K
YoY Change -68.56% 28.73% -23.71% 34.83% 18.67% 47.06% 12.09% -33.58% 26.85% -18.18% 41.94% -5.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $28.00K $26.00K $20.00K $0.00 $3.800M
YoY Change -100.0% 7.69% 30.0% -100.0%
Total Short-Term Liabilities $3.172M $4.688M $3.307M $3.590M $3.350M $2.840M $2.090M $3.260M $8.000M $3.160M $3.500M $2.090M $2.840M $450.0K $350.0K $230.0K $220.0K $370.0K $340.0K $310.0K $160.0K $160.0K
YoY Change -32.34% 41.76% -7.88% 7.16% 17.96% 35.89% -35.89% -59.25% 153.16% -9.71% 67.46% -26.41% 531.11% 28.57% 52.17% 4.55% -40.54% 8.82% 9.68% 93.75% 0.0%
Long-Term Debt $0.00 $0.00 $28.00K $50.00K $0.00 $0.00 $0.00 $0.00 $3.880M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $960.0K $0.00 $0.00
YoY Change -100.0% -44.0% -100.0% -100.0%
Other Long-Term Liabilities $3.387M $7.628M $1.135M $60.00K $260.0K $0.00 $130.0K $1.970M $400.0K
YoY Change -55.6% 572.07% 1791.67% -76.92% -100.0% -93.4% 392.5%
Total Long-Term Liabilities $3.387M $7.628M $1.163M $110.0K $260.0K $0.00 $130.0K $1.970M $4.280M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $960.0K $0.00 $0.00
YoY Change -55.6% 555.89% 957.27% -57.69% -100.0% -93.4% -53.97% -100.0%
Total Liabilities $6.559M $12.32M $4.470M $3.690M $3.610M $2.840M $2.220M $5.230M $12.28M $3.160M $3.500M $2.090M $2.840M $450.0K $350.0K $230.0K $220.0K $370.0K $340.0K $1.270M $160.0K $160.0K
YoY Change -46.74% 175.53% 21.14% 2.22% 27.11% 27.93% -57.55% -57.41% 288.61% -9.71% 67.46% -26.41% 531.11% 28.57% 52.17% 4.55% -40.54% 8.82% -73.23% 693.75% 0.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Basic Shares Outstanding 1.964M 174.0K 6.852M 1.649M
Diluted Shares Outstanding 1.964M 174.0K 6.852M 1.649M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $8.5292 Million

About Nuwellis Inc

Nuwellis Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Eden Prairie, Minnesota and currently employs 59 full-time employees. The company went IPO on 2012-02-16. Nuwellis, Inc. is a medical technology company. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories ALLIED HEALTHCARE PRODUCTS INC MICRON SOLUTIONS INC /DE/ Thermogenesis Holdings Inc INVIVO THERAPEUTICS HOLDINGS CORP. Encision Inc Intelligent Bio Solutions Inc ReShape Lifesciences Inc.